Your email has been successfully added to our mailing list.

×
0 0 -0.0164705882352941 0.00806722689075637 0.00168067226890759 -0.0447058823529411 -0.0703193277310924 -0.0621075630252101
Stock impact report

Better Buy: Editas Medicine or Sangamo Therapeutics? [The Motley Fool]

Editas Medicine, Inc. (EDIT) 
Last editas medicine, inc. earnings: 2/26 04:02 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.editasmedicine.com
Company Research Source: The Motley Fool
Better Buy: Editas Medicine or Sangamo Therapeutics? These gene-editing trailblazers continue advancing exciting new approaches to treating inherited diseases. Gene editing holds tremendous promise to help patients and potentially cure a multitude of inherited diseases. Editas Medicine ( NASDAQ:EDIT ) and Sangamo Therapeutics ( NASDAQ:SGMO ) employ technologies aimed at removing, replacing, or editing sections of the human genome. Editas focuses on a relatively recent technology called CRISPR while Sangamo uses several technologies including what is called zinc finger technology. Both approaches allow for precise gene editing by breaking the DNA strand and either inserting new DNA sequences or deleting sections of damaged or mutated DNA. CRISPR has quickly been adopted as a research tool in labs across the globe. However, translating a powerful tool in the lab into a viable medicine remains an uphill challenge. RNAi, a gene-silencing technology, took close to 16 years before Alnylam Show less Read more
Impact Snapshot
Event Time:
EDIT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for
EDIT alerts

from News Quantified
Opt-in for
EDIT alerts

from News Quantified